The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae

Courtney L. Luterbach, Ashley Boshe, Heather I. Henderson, Eric Cober, Sandra S. Richter, Robert A. Salata, Robert C. Kalayjian, Richard R. Watkins, Andrea M. Hujer, Kristine M. Hujer, Susan D. Rudin, T. Nicholas Domitrovic, Yohei Doi, Keith S. Kaye, Scott Evans, Vance G. Fowler, Robert A. Bonomo, David Van Duin

研究成果: Article

1 引用 (Scopus)

抜粋

In the Consortium on Resistance Against Carbapenems in Klebsiella and other Enterobacteriaceae (CRACKLE), trimethoprim-sulfamethoxazole (TMP-SMX) had a limited role in the treatment of less severe carbapenem-resistant Enterobacteriaceae (CRE) infections, especially urinary tract infections. Of tested CRE, only 29% were susceptible to TMPSMX. Development of resistance further limits the use of TMPSMX in CRE infections.

元の言語English
ジャーナルOpen Forum Infectious Diseases
6
発行部数1
DOI
出版物ステータスPublished - 01-01-2019

    フィンガープリント

All Science Journal Classification (ASJC) codes

  • Oncology
  • Clinical Neurology

これを引用

Luterbach, C. L., Boshe, A., Henderson, H. I., Cober, E., Richter, S. S., Salata, R. A., Kalayjian, R. C., Watkins, R. R., Hujer, A. M., Hujer, K. M., Rudin, S. D., Domitrovic, T. N., Doi, Y., Kaye, K. S., Evans, S., Fowler, V. G., Bonomo, R. A., & Van Duin, D. (2019). The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae. Open Forum Infectious Diseases, 6(1). https://doi.org/10.1093/ofid/ofy351